The Braden Center in Sterling, Illinois, has introduced BrainsWay’s Deep TMS (Deep Transcranial Magnetic Stimulation), a significant advancement in the treatment of treatment-resistant depression (TRD). This...
Incyte Corporation announced on October 29, 2023, that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to its investigational drug, INCA033989. This...
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Incyte’s experimental drug, INCA033989, aimed at treating a rare blood cancer known as...
The U.S. Food and Drug Administration (FDA) has officially extended the review period for the New Drug Application (NDA) concerning Ascendis Pharma’s treatment for children with...
The U.S. Food and Drug Administration (FDA) has initiated a trial program aimed at improving communication with pharmaceutical companies regarding pending drug applications. Launched in October...
A recent study from the University of Waterloo has provided valuable insights into the effectiveness of COVID-19 vaccines against emerging strains of the virus. Conducted by...
The U.S. Food and Drug Administration (FDA) has announced a significant recall of more than 580,000 bottles of the blood pressure medication prazosin hydrochloride. This action...
The U.S. Food and Drug Administration (FDA) has announced a significant recall affecting over 580,000 bottles of the blood pressure medication prazosin hydrochloride. The recall, initiated...
Akebia Therapeutics has announced it will discontinue its efforts to expand the use of Vafseo (vadadustat) for treating anemia in patients with chronic kidney disease (CKD)...
The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Elanco Animal Health for its product Credelio (active ingredient: lotilaner). This authorization...
